Selecting the appropriate intracellular domain (e.g., 4‐1BB, FLT3 or CD40) of CAR can induce the mature phenotype of CAR‐DC when recognising the tumour, and overcome the acclimation of tolerant DC cells by the suppressive TME. The gene discussed is FLT3; the disease is neoplasm.